Welcome to Advances in Clinical and Experimental Medicine, an esteemed publication by WROCLAW MEDICAL UNIVERSITY, dedicated to advancing the essential fields of clinical and experimental medicine. With an open access model since 2017, this journal ensures that researchers, healthcare professionals, and students worldwide can freely access high-quality scientific content. Covering a broad spectrum of topics including biochemistry, genetics, internal medicine, and pharmacology, Advances in Clinical and Experimental Medicine has established itself as a pivotal resource in the scientific community, currently holding prestigious rankings such as Q2 in Biochemistry, Genetics, and Molecular Biology (miscellaneous) and Q1 in Reviews and References (medical) for 2023. Spanning over two decades of rigorous research publication, the journal is a critical platform for sharing innovative findings and fostering collaboration among scholars, making it an invaluable asset for those at the forefront of medical science.

Experimental and Therapeutic Medicine is a distinguished peer-reviewed journal published by SPANDIDOS PUBL LTD, focusing on the dynamic fields of Immunology, Microbiology, and Cancer Research. With its ISSN 1792-0981 and E-ISSN 1792-1015, this journal holds a notable position in the research community, contributing valuable insights into experimental methodologies and therapeutic strategies that advance understanding in these critical areas. Although the journal's coverage in Scopus was discontinued after 2018, it continues to serve as a resource for emerging studies and novel discoveries, evidenced by its ranking within the 37th percentile in Immunology and Microbiology, and the 17th percentile in Cancer Research. Researchers, professionals, and students alike can benefit from its rigorous articles and comprehensive reviews, further enhancing their comprehension of the vibrant landscape of modern medicine. Explore this journal to discover pivotal findings that shape the future of healthcare.

Biochemistry Moscow-Supplement Series B-Biomedical Chemistry, published by MAIK NAUKA-INTERPERIODICA, is a pivotal journal in the fields of biochemistry, clinical biochemistry, and molecular medicine. Established in 2008, the journal serves as a vital platform for researchers and professionals seeking to disseminate and access groundbreaking research in the biomedical sciences. With an ISSN of 1990-7508 and an E-ISSN of 1990-7516, the journal has been recognized in the Q4 quartile across various categories as of 2023, highlighting its emerging presence in the academic community despite a competitive landscape. Although currently not available as Open Access, the journal encompasses a broad spectrum of studies, ranging from theoretical analysis to practical applications in biomedical research. The journal's dedicated focus on advancing our understanding of biochemical principles positions it as an essential resource for students and professionals alike, enhancing its significance in the global scientific dialogue.

The Annual Review of Medicine is a prestigious academic journal published by Annual Reviews that serves as a key resource for researchers, healthcare professionals, and students engaged in the fields of medicine and biochemistry. With its ISSN 0066-4219 and E-ISSN 1545-326X, this journal has been providing comprehensive reviews that cover major developments and trends in medical research since its inception in 1950. Impactful in its category, the Annual Review of Medicine ranks in the Q1 quartile for both Medicine (miscellaneous) and Biochemistry, Genetics and Molecular Biology (miscellaneous), establishing itself within the top percentiles of academic rigor and relevance, exemplified by its impressive Scopus rankings: Rank #12/636 and Rank #6/221 respectively. Although the journal is not open access, it remains an essential resource for contributing valuable insights into evolving medical disciplines, driving evidence-based practice, and fostering innovation among healthcare researchers. The Annual Review of Medicine is instrumental in shaping the future of medicine by synthesizing the most critical findings and fostering an informed understanding of diverse medical challenges.

Journal of Translational Medicine, published by BMC in the United Kingdom, stands at the forefront of biomedical research, bridging the gap between laboratory discoveries and clinical applications. Established in 2003 as an Open Access journal, it has garnered significant recognition, achieving a Q1 quartile ranking in both Biochemistry, Genetics and Molecular Biology and Medicine categories as of 2023. With an impressive Scopus rank of 38 out of 636 in General Medicine and 33 out of 221 in General Biochemistry, Genetics and Molecular Biology, the journal is committed to disseminating high-quality, peer-reviewed research that impacts healthcare and informs clinical practices. By facilitating free access to groundbreaking studies, the Journal of Translational Medicine aims to enhance collaboration among researchers, professionals, and students in the scientific community, fostering advancements in translational research well into the future.

IN VIVO is a prestigious academic journal published by the International Institute of Anticancer Research, dedicated to advancing the fields of biochemistry, genetics, molecular biology, cancer research, and pharmacology. With its ISSN 0258-851X and E-ISSN 1791-7549, this journal has been a key contributor to innovative research since its inception in 1987, providing a crucial platform for the dissemination of significant findings in its scope. With an impressive impact reflected in its quartile rankings (Q2 in Biochemistry, Genetics and Molecular Biology and Medicine; Q3 in Cancer Research and Pharmacology), IN VIVO reaches a global audience comprising researchers, health professionals, and students. Although it operates on a subscription basis, the journal’s commitment to scientific excellence and rigorous peer review ensures that all published works maintain high quality and relevance. Notably positioned in Scopus ranks within the 36th to 59th percentiles across various categories, IN VIVO continues to be a vital resource for cutting-edge research and developments, solidifying its importance within the scientific community.

Acta Naturae is a peer-reviewed scientific journal published by the Russian Federation Agency for Science & Innovation, focusing on the dynamic fields of Biochemistry, Biotechnology, Molecular Biology, and Molecular Medicine. Launched in 2013, the journal has established a solid reputation in the academic community, with its articles contributing to essential advancements and discussions within these disciplines. By 2023, it has achieved notable rankings—including Q2 status in Biotechnology and Q3 in Biochemistry, Molecular Biology, and Molecular Medicine—indicating its growing influence and relevance in the scientific literature. While currently operating under a non-open access model, Acta Naturae invites researchers, professionals, and students to engage with its comprehensive research reports and reviews that span the breadth of molecular life sciences. With the aim of facilitating scientific dialogue and innovation, this journal serves as a key resource for those seeking to stay at the forefront of molecular research.

Science China-Life Sciences, published by SCIENCE PRESS, is a premier academic journal that stands at the forefront of innovative research and discoveries in the fields of life sciences, spanning crucial areas such as agricultural and biological sciences, biochemistry, genetics, molecular biology, and environmental science. With an impressive Q1 ranking in its respective categories—ranked #5 in Agricultural and Biological Sciences, #7 in Environmental Science, and #17 in Biochemistry, Genetics and Molecular Biology—this journal is recognized for its rigorous peer-review process and significant impact within the scientific community, as reflected in its high percentiles (97th and 92nd). Maintained as an Open Access publication, it ensures broad dissemination and accessibility of research findings, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. Given its position in the research landscape and its commitment to high-quality scholarship, Science China-Life Sciences plays a vital role in advancing life sciences research, supporting scientists in addressing global challenges through innovative biological solutions.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, published by Elsevier, is a pivotal journal in the fields of Molecular Biology and Molecular Medicine, recognized for its high impact factor and robust ranking within Scopus categories, holding prestigious quartiles in Q1 for both disciplines as of 2023. With ISSN 0925-4439 and E-ISSN 1879-260X, this journal fosters cutting-edge research from 1990 to 2025, addressing the critical molecular mechanisms underlying human diseases. Its wide-ranging scope includes original research articles, reviews, and advanced theoretical insights, serving as an essential resource for researchers, clinicians, and students alike. The journal is based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, and while it does not currently offer an open-access option, it continues to maintain a strong presence in the scientific community, enhancing our understanding of molecular processes in health and disease.

Gazi Medical Journal, an esteemed publication by GALENOS PUBL HOUSE, is a prominent platform in the field of medicine, dedicated to the dissemination of innovative research and critical reviews in diverse medical disciplines. Established in 1992 and transitioning to an Open Access model in 2005, this journal aims to promote unrestricted access to valuable medical knowledge, enhancing the reach and impact of research contributions. With a growing presence in the academic community, it currently holds a Q4 quartile ranking in the category of Medicine (miscellaneous) for 2023, and it ranks at #528 out of 636 in the realm of General Medicine on Scopus, representing the 16th percentile. The journal covers a wide array of topics, making it a vital resource for researchers, healthcare professionals, and students eager to stay informed about the latest medical advancements and practices. Located in the heart of Istanbul, Turkey, Gazi Medical Journal welcomes submissions that inspire thought, spark innovation, and contribute to the ongoing discourse in the medical field.